SERPINA1 and pulmonary emphysema: AAT infusions (e.g., Prolastin®) were approved for maintenance therapy of AAT-deficient patients suffering from emphysema and are generally well tolerated, but the efficiency of this treatment regarding emphysema is at best mediocre (10).